Literature DB >> 14584892

Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway.

Shilpa Choudhary1, Sunil Wadhwa, Lawrence G Raisz, Cynthia Alander, Carol C Pilbeam.   

Abstract

UNLABELLED: [Ca2+]e may be important in bone turnover. We found [Ca2+]e induces COX-2 transcription and PGE2 production in primary calvarial osteoblasts through an ERK signaling pathway. Inhibition of PGE2 production inhibited the [Ca2+]e stimulation of osteoblastic differentiation but not the increase in cell number. Hence, some effects of [Ca2+]e on bone may be mediated by COX-2.
INTRODUCTION: Local changes in extracellular calcium ([Ca2+]e) may play an important role in bone turnover. We examined the possibility that prostaglandins produced by cyclo-oxygenase-2 (COX-2) could mediate some of the effects of [Ca2+]e on osteoblasts.
METHODS: We examined the [Ca2+]e induction of COX-2 expression and prostaglandin E2 (PGE2) production in primary osteoblasts (POBs) obtained by sequential enzymatic digestion of mouse calvariae. We measured mRNA and protein levels by Northern and Western analyses and PGE2 production in culture medium by radioimmunoassay (RIA). COX-2 promoter activity was measured as luciferase activity in calvarial osteoblasts derived from mice transgenic for 371 bp of the COX-2 promoter fused to a luciferase reporter gene. RESULTS AND
CONCLUSIONS: COX-2 mRNA and protein expression were induced by 3-40 mM of [Ca2+]e. [Ca2+]e (5 mM) induced COX-2 mRNA within 30 minutes; levels peaked at 6-9 h and remained elevated at 24 h. Cumulative medium PGE2 was increased at 3 h, with levels rising to 30 nM at 24 h. PGE2 production in POBs from mice with only COX-1 gene expression was 1/40th of that in POBs from mice with both COX-1 and COX-2 gene expression. [Ca2+]e increased alkaline phosphatase activity and osteocalcin mRNA, and this increase was blocked by inhibiting PGE2 production. [Ca2+]e stimulation of COX-2 promoter activity correlated with the induction of COX-2 mRNA expression. [Ca2+]e induced rapid and transient phosphorylation of extracellular signal-regulated kinase (ERK) in POBs, which peaked at 5-10 minutes. Inhibition of ERK phosphorylation with the specific inhibitors, PD-98059 and U-0126, decreased the [Ca2+]e induction of both COX-2 mRNA and luciferase activity by 70-80%. Although less effective than [Ca2+]e, strontium [Sr2+]e also induced COX-2 mRNA and promoter activity in POBs through an ERK signaling pathway. We conclude that [Ca2+]e is a potent transcriptional inducer of COX-2 expression and PGE2 production in osteoblasts through an ERK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584892     DOI: 10.1359/jbmr.2003.18.10.1813

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

1.  The bio-functional role of calcium in mesoporous silica xerogels on the responses of osteoblasts in vitro.

Authors:  Huanjun Zhou; Jie Wei; Xiaohui Wu; Jianlin Shi; Changsheng Liu; Junfeng Jia; Chenglong Dai; Qi Gan
Journal:  J Mater Sci Mater Med       Date:  2010-04-22       Impact factor: 3.896

2.  Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: an open, prospective study.

Authors:  Melek Eda Ertorer; Okan Bakiner; Inan Anaforoglu; Nurzen Sezgin; Nilgun Guvener Demirag; Neslihan Bascil Tutuncu
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

Review 3.  Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress.

Authors:  Jean Xin Jiang; Arlene Janel Siller-Jackson; Sirisha Burra
Journal:  Front Biosci       Date:  2007-01-01

4.  In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering.

Authors:  Fei Liu; Xu Zhang; Xixun Yu; Yuanting Xu; Ting Feng; Dawei Ren
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

5.  Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

Authors:  Manshan Xu; Shilpa Choudhary; Olga Voznesensky; Qi Gao; Douglas Adams; Vilmaris Diaz-Doran; Qian Wu; David Goltzman; Lawrence G Raisz; Carol C Pilbeam
Journal:  Bone       Date:  2010-05-13       Impact factor: 4.398

6.  Identification of a novel extracellular cation-sensing G-protein-coupled receptor.

Authors:  Min Pi; Pieter Faber; George Ekema; P David Jackson; Anthony Ting; Nancy Wang; Michelle Fontilla-Poole; Robert W Mays; Kurt R Brunden; John J Harrington; L Darryl Quarles
Journal:  J Biol Chem       Date:  2005-09-30       Impact factor: 5.157

7.  Compositional and histological comparison of carbonate apatite fabricated by dissolution-precipitation reaction and Bio-Oss®.

Authors:  Kenji Fujisawa; Kazuya Akita; Naoyuki Fukuda; Kumiko Kamada; Takaharu Kudoh; Go Ohe; Takamitsu Mano; Kanji Tsuru; Kunio Ishikawa; Youji Miyamoto
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

8.  The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.

Authors:  Maria Teresa Valenti; Sandro Giannini; Luca Donatelli; Mirko Zanatta; Francesco Bertoldo; Stefania Sella; Maria Teresa Vilei; Elena Ossi; Giuseppe Realdi; Vincenzo Lo Cascio; Luca Dalle Carbonare
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

9.  Activation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2+)- and ATP-dependent in MC3T3-E1 osteoblasts.

Authors:  Dawei Liu; Damian C Genetos; Ying Shao; Derik J Geist; Jiliang Li; Hua Zhu Ke; Charles H Turner; Randall L Duncan
Journal:  Bone       Date:  2007-10-16       Impact factor: 4.398

10.  Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro.

Authors:  Zheng Xu; Shilpa Choudhary; Yosuke Okada; Olga Voznesensky; Cynthia Alander; Lawrence Raisz; Carol Pilbeam
Journal:  Bone       Date:  2007-03-21       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.